Recent Articles

November 7, 2016 10:30 am
Matt Gruver, , Product Manager, Informatics & Chromatography Software, Thermo Fisher Scientific
There are many reasons why promising drug compounds fail in the early stages of development, but many see inefficiency as a culprit. To help labs get started, we’ve identified five problem areas that, when addressed, will have an immediate impact on efficiency and productivity.
October 24, 2016 11:24 am
Michael McManus, Ph.D., Senior Health and Life Sciences Solution Architect, Intel
If the world’s nations needed to begin whole genome sequencing (WGS) of everyone on the planet—approximately 7.3 billion people—what kind of IT resources would that require: storage, compute, and energy requirements?
October 19, 2016 11:07 am
Jon Chesnut, Senior Director of Synthetic Biology R&D, Thermo Fisher Scientific
TALEN and CRISPR each come with certain advantages that scientists must consider before deciding which tool to use.
Subscribe to Bioscience Technology